USPTO serial 97054612
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
David Schnider
David Schnider NOLAN HEIMANN LLP16000 Ventura Blvd., Ste 1200ENCINO, CA 91436UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Development of quality control standards for testing and medical treatment procedures for individuals infected with COVID-19 and other infectious diseases; Research and development of pharmaceuticals and medical procedures for the treatment of individuals infected with COVID-19 and other infectious diseases; Scientific study and research regarding effective treatment protocols for individuals infected with COVID-19 and other infectious diseases | ACTIVE | Apr 15, 2020 |
| 044 | providing medical information in the nature of providing and preparing medical treatment protocols for individuals infected with COVID-19 and other infectious diseases; Providing a web site that gives medical information about the treatment of COVID-19 and other infectious diseases | ACTIVE | Apr 15, 2020 |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| May 26, 2022 | MAB1 | ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT | — |
| May 26, 2022 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| May 25, 2022 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Oct 28, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 7, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 7, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 7, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 4, 2021 | NWAP | NEW APPLICATION ENTERED | — |